Sanzgiri U Y, Kim H J, Muralidhara S, Dallas C E, Bruckner J V
Department of Pharmacology and Toxicology, College of Pharmacy, University of Georgia, Athens 30602-2356, USA.
Toxicol Appl Pharmacol. 1995 Sep;134(1):148-54. doi: 10.1006/taap.1995.1178.
The objectives of this study were to evaluate the influence of both route and pattern of exposure on the pharmacokinetics (PK) and target organ toxicity of a common volatile organic chemical, carbon tetrachloride (CCl4). Male Sprague-Dawley rats, 325-375 g, inhaled 100 or 1000 ppm CCl4 for 2 hr through a one-way breathing valve. The total amount of CCl4 retained by each rat (i.e., the systemically absorbed dose) during the 2-hr period was determined to be 17.5 and 179 mg CCl4/kg body wt, respectively. CCl4, in doses of 17.5 and 179 mg/kg body wt, was administered in an aqueous emulsion by bolus gavage or by constant gastric infusion over 2 hr. Serial micro blood samples from the animals were analyzed for CCl4, in order to delineate blood concentration-versus-time profiles. Serum enzyme activities and total liver microsomal cytochrome P450 level and glucose 6-phosphatase activity were measured 24 hr postdosing as indices of CCl4 hepatotoxicity. The pattern of oral exposure, or dosage regimen, had a significant effect on the PK and acute the hepatotoxicity of CCl4. Arterial blood levels in the gastric infusion group were much lower than in the oral bolus group with both doses. Since CCl4 is quickly and extensively absorbed from the GI tract, large amounts of CCl4 in the portal blood following the oral bolus apparently exceeded the capacity of the liver to metabolize the chemical. Thus, substantially higher Cmax and AUC0 integral of infinity values were manifest. Hepatotoxicity was also significantly greater in these animals. The route of exposure also had a significant effect on the PK of CCl4. Levels of CCl4 in the arterial blood were much higher during inhalation than during gastric infusion. However, AUC0 integral of infinity vales for the two groups were not significantly different, due to relatively slow elimination after gastric infusion. There was little difference between the two groups in hepatotoxicity indices 24 hr postdosing.
本研究的目的是评估暴露途径和模式对一种常见挥发性有机化合物四氯化碳(CCl4)的药代动力学(PK)和靶器官毒性的影响。体重325 - 375克的雄性Sprague-Dawley大鼠通过单向呼吸阀吸入100或1000 ppm的CCl4,持续2小时。在这2小时期间,每只大鼠保留的CCl4总量(即全身吸收剂量)分别确定为17.5和179毫克CCl4/千克体重。以17.5和179毫克/千克体重的剂量,通过大剂量灌胃或在2小时内持续胃内输注的方式,将CCl4制成水乳液给药。采集动物的系列微量血样分析CCl4,以描绘血药浓度-时间曲线。给药后24小时测量血清酶活性、肝脏微粒体细胞色素P450总水平和葡萄糖6-磷酸酶活性,作为CCl4肝毒性的指标。口服暴露模式或给药方案对CCl4的药代动力学和急性肝毒性有显著影响。两种剂量下,胃内输注组的动脉血水平均远低于口服大剂量组。由于CCl4可迅速且广泛地从胃肠道吸收,口服大剂量后门静脉血中的大量CCl4显然超过了肝脏代谢该化学物质的能力。因此,出现了显著更高的Cmax和AUC0至无穷大积分值。这些动物的肝毒性也明显更大。暴露途径对CCl4的药代动力学也有显著影响。吸入期间动脉血中的CCl4水平远高于胃内输注期间。然而,由于胃内输注后消除相对缓慢,两组的AUC0至无穷大值无显著差异。给药后24小时,两组的肝毒性指标差异不大。